Build and lead commercial data, advanced analytics, and forecasting capabilities to support launch readiness.
Develop patient-based forecasts and decision-support models to guide commercial strategy.
Translate complex data into actionable insights and KPIs for senior executives and operating teams.
REGENXBIO is a gene therapy company advancing a pipeline of treatments for rare and retinal diseases. The culture is purpose-driven and collaborative, with a focus on making a meaningful difference for patients and their families.
Build and lead field operations infrastructure for Definium's first commercial launch, including territory management, CRM workflows, and incentive compensation.
Partner with Commercial Analytics, Field Strategy, IT, and cross-functional teams to translate commercial strategy into reliable field processes.
Scale operations from pre-launch through commercialization while ensuring data integrity, compliance, and vendor oversight.
Definium Therapeutics is a late-stage clinical biopharmaceutical company applying scientific rigor to psychedelics to develop treatments for psychiatric and neurological disorders. Headquartered in New York and trading on Nasdaq, the company is advancing a lean, collaborative culture focused on turning evidence into impact.
Own the Field Excellence operating model nationally, including cadence, standards, tools, and escalation protocols.
Serve as the single operational partner to the VP Sales, managing territory, IC questions, and business review preparation.
Manage and develop two Directors of Field Excellence and ensure launch readiness across all geographies.
Summit Therapeutics is a biopharmaceutical oncology company focused on improving quality of life and resolving serious unmet medical needs through clinical studies. The company is building its commercial infrastructure for a first US launch, with a mission-driven culture emphasizing integrity, collaboration, and commitment to people.
Own the overall rare disease franchise strategy, business performance, and P&L with full accountability for revenue, profitability, and commercial objectives.
Lead the commercial strategy and launch of RGX-202 while shaping the growth and evolution of the rare disease franchise.
Partner cross-functionally to turn strategy into execution and deliver meaningful outcomes for patients, providers, and the company.
We are a biotechnology company pioneering what's possible in gene therapy, advancing a pipeline of therapies for serious rare and retinal diseases. We are a growing company with a talented, collaborative team passionate about making a meaningful difference for patients and their families.
Owns the strategy, governance, and evolution of field intelligence capabilities, including analytics requirements, measurement frameworks, and capability roadmaps.
Consolidates and prioritizes field-related analytics and decision-support requirements across Insights & Analytics, partnering with strategy, platforms, and technology teams.
Serves as the primary coordination point for field intelligence and CRM analytics, operating in a globally integrated capability model.
Novartis is a global healthcare company that develops innovative science to improve the lives of people living with disease. It is a large, inclusive organization that values collaboration and empowers employees to reach their full potential.
Build and maintain territory-level performance dashboards and scorecards for the US field organization.
Develop sub-national analyses including geographic demand modeling, ATC penetration analytics, and field force effectiveness.
Partner with commercial data systems to ensure data quality and deliver actionable insights to field leadership.
Iovance Biotherapeutics develops tumor infiltrating lymphocyte (TIL) cell therapies for solid tumors, including the FDA-approved Amtagvi for advanced melanoma. They are an end-to-end cell therapy company with centralized U.S. manufacturing and a growing commercial network.
Drives promotional effectiveness analytics for TRUTAKNA, including ROI analysis and channel measurement.
Supports patient-based demand forecasting and reconciles demand signals with financial projections.
Partners with cross-functional teams to translate business questions into analytical plans and deliver executive-level insights.
Vera Therapeutics is a commercial-stage biotechnology company focused on transforming medicine in autoimmune disease, starting with the kidney. The company values empathy, ownership, clarity, and urgency, fostering a lean, collaborative culture.
Lead the development and implementation of commercial field operations capabilities for a major pharmaceutical product launch.
Oversee field infrastructure, territory management, CRM workflows, incentive compensation, and performance reporting.
Collaborate with cross-functional teams including commercial, analytics, IT, finance, and compliance to ensure operational excellence.
A late-stage biopharmaceutical company advancing innovative treatments for psychiatric and neurological conditions. They offer a fast-paced, collaborative environment focused on building launch-ready capabilities.
Build and lead the DACH commercial field team, from pre-launch education to key account management.
Own launch plans for ADH1 and achondroplasia, including local marketing and forecasting.
Partner with Medical Affairs, Market Access, and Patient Advocacy for coordinated launch execution.
BridgeBio Pharma is a biotech that uses a 'moneyball' model to fund early-stage research and develop medicines for rare diseases and genetically driven cancers. It values curiosity, experimentation, and a hands-on culture, rewarding high performers.